Paediatric & Population-Based Dermatology

St John’s Institute of Dermatology, Guys and St Thomas’ NHS Trust and Kings College London. Cutting edge research group led by Professor Carsten Flohr.

[Paediatric & Population-Based Dermatology @PPopDerm]

🌍 Grand Challenges in Global Skin Health Revisited 🌍

https://t.co/fftoJ6Jg57

[Paediatric & Population-Based Dermatology @PPopDerm]

Earlier this month, the TRANS-FOODS Consortium met in Paris, hosted by Dr. Elodie Segura at the Institute Necker Enfants Malades - Inserm, Université Paris.

[Paediatric & Population-Based Dermatology @PPopDerm]

Back from a packed EADV Congress in Paris!
Professor Flohr presented on the latest findings from the UK-Irish A-STAR register and spoke on ‘Atopic Dermatitis in Children’.
Catch up on the highlights here: https://t.co/JXwo1fXLVT

[Paediatric & Population-Based Dermatology @PPopDerm]

📓 EADV2025 Book of the Conference! 📓

Delighted to see our Handbook of Skin Disease Management voted as the 'Book of the Conference' at the European Academy of Dermatology and Venereology Congress 2025 in Paris by https://t.co/YTkSafgj48.

[Paediatric & Population-Based Dermatology @PPopDerm]

Congratulations to Stuart Jones, Elodie Segura from the TRANS-FOODS consortium on leading on this Cell publication:

Transient skin stretching mimicking skin massage stimulates immune surveillance and promotes vaccine delivery via hair follicles: https://t.co/ngDvrM1tYt

[Paediatric & Population-Based Dermatology @PPopDerm]

🌍 Making a difference to those living with eczema - join us in celebrating World Eczema Day!

Check us out on https://t.co/k3S2Ueq4Uj to find out more about what we do.

[Paediatric & Population-Based Dermatology @PPopDerm]

How are the mind and skin connected? 🧠✨🩵
Watch our newest video on the Mind and Skin study here:
https://t.co/KQCkeNZSjr

[Paediatric & Population-Based Dermatology @PPopDerm]

Hot off the press: TRANS-FOODS paper shows handwashing removes up to 90% of peanut protein from the skin

#peanutallergy #foodallergy #transcutaneoussensitization #atopicdermatitis #eczema

[Paediatric & Population-Based Dermatology @PPopDerm]

The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children: results from the TREAT trial
🔗 https://t.co/mxuzGHcMwI

[Paediatric & Population-Based Dermatology @PPopDerm]

Revisiting our health economic analysis from the TREAT trial published in the British Journal of Dermatology!

Methotrexate versus ciclosporin in the treatment of severe atopic eczema in children: an economic evaluation
🔗 https://t.co/Ov0RA2yazm

[Paediatric & Population-Based Dermatology @PPopDerm]

We’re excited to share our latest findings from the UK TREAT Trial, now published open access in BJD:
Methotrexate and ciclosporin improve skin biomarkers in paediatric atopic dermatitis
🔗 https://t.co/7p5KWpKj4B

[Paediatric & Population-Based Dermatology @PPopDerm]

Our 'living' update of the European guideline for the treatment of atopic eczema has just appeared: https://t.co/B2myQwcTvw
A special 'thank you' to all members, in particular co-lead Professor Andreas Wollenberg and the EuroGuiDerm Centre team in Berlin.
#eczema #treatment

[Paediatric & Population-Based Dermatology @PPopDerm]

🌟 We're Hiring! 🌟
https://t.co/ftmlJ1sspI

[Paediatric & Population-Based Dermatology @PPopDerm]

UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR) hits 1000th patient milestone! 🎉

👏 Congratulations to the Norfolk and Norwich team and their colleagues who recruited this patient.

📩 Interested in joining the A-STAR study? Contact us at: [email protected]

[Global Atopic Dermatitis Atlas (GADA) @globalADatlas]

Wrapping up an inspiring #ISADSociety conference in #Doha! 🌍 Grateful for the chance to connect, learn and share insights with experts from around the world. Here's to continued collaboration and advancements in dermatology for better patient care everywhere #AtopicDermatitis

[Paediatric & Population-Based Dermatology @PPopDerm]

Dr Helen Alexander presented at the ISAD conference, providing an overview of the TREAT trial immunology results and highlighting the key finding that MTX and CyA modulate skin and systemic immune markers with MTX showing a more sustained effect after treatment cessation.

[Global Atopic Dermatitis Atlas (GADA) @globalADatlas]

🚀 @globalADatlas is making strides in addressing gaps in the global burden map for atopic dermatitis. Check out our latest update for ongoing and upcoming work: https://t.co/fQa8F7ZmQ8 🌍
#AtopicDermatitis #SkinHealth #EczemaAwarenessMonth #GlobalHealth #Dermatology #Eczema

[Paediatric & Population-Based Dermatology @PPopDerm]

Professor Carsten Flohr is just back from British Society for Allergy and Clinical Immunology Annual Conference, speaking on biologics in atopic dermatitis and contributing to a panel discussion on multisystem allergic disease.

[Paediatric & Population-Based Dermatology @PPopDerm]

🏃‍♂️🏃‍♀️ Our Paediatric & Population-Based Dermatology Research Team is taking on the Great South Run to raise funds for the National Eczema Society and support life-changing eczema research! 💙

https://t.co/8agm66w2ai

🔗 Link in bio to donate!

[Paediatric & Population-Based Dermatology @PPopDerm]

🎉 Exciting news! We’ve just recruited the first adolescent in the UK for the COAST-2 clinical trial! This trial uses amlitelimab, an OX-40 ligand monoclonal antibody, to explore new ways to treat atopic dermatitis.